Institutional Ownership
Taysha Gene Therapies Inc
CUSIP 877619106COM SHSTSHAQ1 2026
13D / 13G Filings
50
Schedule 13D/13G on record
Beneficial Filers
20
Distinct reporting persons
Largest Stake
25.5%
Max % of class reported
Institutional Holders
185
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
50 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Rtw Investments, LP | 13G/A | 8.3% | 23.41M | SEC |
| 2 | Feb 17, 2026 | Vestal Point Capital, LP | 13G | 5.0% | 13.75M | SEC |
| 3 | Feb 5, 2026 | Fmr LLC | 13G/A | 4.9% | 13.53M | SEC |
| 4 | Jan 21, 2026 | Blackrock, Inc. | 13G/A | 6.5% | 17.85M | SEC |
| 5 | Nov 14, 2025 | Ra Capital Management, L.P. | 13G/A | 9.9% | 27.66M | SEC |
| 6 | Nov 14, 2025 | Octagon Capital Advisors LP | 13G/A | 3.3% | 9.07M | SEC |
| 7 | Aug 14, 2025 | Ra Capital Management, L.P. | 13G/A | 9.9% | 25.35M | SEC |
| 8 | Aug 14, 2025 | Rtw Investments, LP | 13G/A | 9.9% | 25.18M | SEC |
| 9 | Aug 6, 2025 | Morgan Stanley | 13G/A | 6.7% | 16.86M | SEC |
| 10 | Aug 6, 2025 | Fmr LLC | 13G/A | 6.2% | 15.63M | SEC |
40 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Taysha Gene Therapies Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 23.56M | $105.29M |
| 2 | Goldman Sachs Group Inc | 22.37M | $99.99M |
| 3 | Avoro Capital Advisors LLC | 21.70M | $97.00M |
| 4 | Blackrock, Inc. | 18.37M | $82.09M |
| 5 | Vestal Point Capital, LP | 18.00M | $80.46M |
| 6 | Morgan Stanley | 17.97M | $80.31M |
| 7 | Fmr LLC | 14.32M | $64.02M |
| 8 | Rtw Investments, LP | 13.68M | $61.15M |
| 9 | State Street Corp | 11.21M | $50.10M |
| 10 | Octagon Capital Advisors LP | 8.86M | $39.60M |